COVID-19: NORC at the University of Chicago and the BMSM Initiative demonstration sites are working together with the HRSA HIV/AIDS Bureau (HAB) to move the Initiative forward during the COVID-19 Public Health Emergency. Please visit the HAB website for additional information:
Coronavirus 2019 (COVID-19) Frequently Asked Questions.
The ETAP's efforts on this project are guided by four goals:
The ETAP will provide TA and CBA to the recipients in areas of intervention adaptation, implementation,
and evaluation. The ETAP will provide training and other resources and tools specifically tailored to
the selected evidence-informed interventions and/or models of care. The ETAP will assess recipient
TA/CBA needs and will be responsible for the provision of evaluation-related TA to the recipients.
These overall TA/CBA goals will be achieved through regular face-to-face meetings, site visits, website
resources, office hours, and monthly teleconferences with the grantees and designated HRSA program
staff over the course of the project.
To support the HRSA SPNS team in its efforts to evaluate community-based efforts to improve
health outcomes among BMSM living with HIV, the ETAP will conduct a national multi-site, mixed-methods
evaluation of the Initiative, which will synthesize findings across all recipients to assess
implementation, outcomes, and overall performance of the Initiative. The MSE aims are to: (1) assess
processes associated with implementing evidence-informed interventions, including barriers and
facilitators to implementation; (2) assess whether the evidence-informed interventions impact clinical
and behavioral outcomes; (3) assess the costs of adapting and implementing the interventions/MOCs
by measuring labor and programmatic costs and expenditures incurred by each site.
The ETAP will conduct a Culturally Responsive Evaluation (CRE) of the Initiative. CRE is a holistic,
theoretical framework that centers an evaluation in culture and guides the evaluation to ensure
that culturally defined values and beliefs influence all steps in the evaluation (e.g., design, evaluation
questions, instrument development, etc.). Using a CRE framework requires that evaluators remain
steadfastly attentive to how race, culture, racism, sexual orientation, homelessness, and poverty
influence and intersect to influence adaptation, and implementation and contribute to expected Initiative
outcomes to improve target population health outcomes along the HIV continuum.
Identifying and sharing best practices and lessons learned from this Initiative is a major priority for
the ETAP. The ETAP will identify federal and grant recipient partners, with expertise in the areas of
product development, health communications, and data visualization, to participate in a publications
and disseminations committee. With the guidance of this committee, the ETAP will develop a range of
dissemination products, including implementation manuals, toolkits, and a final report. The ETAP will
also engage this committee to identify target audiences for each product, as well as possible venues
Another goal of the ETAP, and complimentary to dissemination, is to promote the replication of
successful interventions/MOCs. The ETAP will work with the AIDS Education and Training Centers
(AETC) to determine the best way to promote replication among their stakeholders. Possible formats
may include webinars, toolkits, and stakeholder websites. Sources of information for replicationfocused
products will include evaluation reports, peer-reviewed manuscripts, briefs, program protocols,
and other materials generated during the course of the evaluation, as well as implementation manuals.
Possible topics included in these products include: